Growing community of inventors

Milan, Italy

Maurizio D'Incalci

Average Co-Inventor Count = 2.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Maurizio D'IncalciDario Ballinari (19 patents)Maurizio D'IncalciEnrico Pesenti (14 patents)Maurizio D'IncalciKay Noel (1 patent)Maurizio D'IncalciJuergen Moll (2 patents)Maurizio D'IncalciRafaella Giavazzi (0 patent)Maurizio D'IncalciNaoto Takahashi (0 patent)Maurizio D'IncalciGlynn Thomas c/o Pharmamar Usa Inc Faicloth (0 patent)Maurizio D'IncalciAndreas Gescher (0 patent)Maurizio D'IncalciSteve c/o Institute For Drug Development Weitman (0 patent)Maurizio D'IncalciMaurizio D'Incalci (1 patent)Dario BallinariDario Ballinari (19 patents)Enrico PesentiEnrico Pesenti (14 patents)Kay NoelKay Noel (2 patents)Juergen MollJuergen Moll (2 patents)Rafaella GiavazziRafaella Giavazzi (0 patent)Naoto TakahashiNaoto Takahashi (0 patent)Glynn Thomas c/o Pharmamar Usa Inc FaiclothGlynn Thomas c/o Pharmamar Usa Inc Faicloth (0 patent)Andreas GescherAndreas Gescher (0 patent)Steve c/o Institute For Drug Development WeitmanSteve c/o Institute For Drug Development Weitman (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Oncoethix Gmbh (1 from 4 patents)

2. Nerviano Medical Sciences S.r.l. (138 patents)

3. Pharma Mar, S.a. (89 patents)


1 patent:

1. 9968619 - Method of treating triple-negative breast cancer using thienotriazolodiazepine compounds

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/8/2026
Loading…